Sygnis AG (XTRA:LIO1) entered into a binding agreement to acquire C.B.S. Scientific Co. Inc. for $0.9 million on December 21, 2016. Under the terms of the agreement, Sygnis will pay $0.54 million in cash and remaining $0.36 million in form of 0.27 million new shares. The cash portion will be funded from existing cash balances of Sygnis AG and equity portion will be issued from authorized capital. The acquisition of C.B.S. is anticipated to be earnings enhancing and cash generative from the onset. Thorsten Kuthe, Meike Dresler-Lenz and Christopher Görtz of Heuking Kühn Lüer Wojtek, acted as a legal advisor for Sygnis AG. Raimund Gabriel of MC Services AG acted as financial advisor for Sygnis AG. Sygnis AG (XTRA:LIO1) completed the acquisition of C.B.S. Scientific Co. Inc. in early January 2017. As of April 11, 2017, Sygnis completed the integration of C.B.S. Scientific.